The MyHearIQ app has a custom-fit feature that helps customers customize their hearing aids to their needs. Because the company is direct-to-consumer, these features give them an edge in the industry.
The company is projected to install Hearing Screening Kiosks in several retail locations and has made free hearing screening tests available on the MyHearIQ website and app. If ever a company tried to bring convenience to hearing assistance and screenings, InnerScope is it. InnerScope Hearing is an over-the-counter stock. Though based in the United States, InnerScope Hearing Technologies not only has the potential to reach a massive amount of American consumers, the company’s global efforts to find the best technology and partners open it up to a potential global presence. The company was founded by Marvin Posey, an early innovator of modern hearing aid technology, in the 1950s. InnerScope Hearing is a US-based hearing solutions company. Should the company continue to scope smart acquisitions, we could see further innovation strategies and steady growth. Something else to keep in mind, GN Group has a history of acquisitions, and these have worked well for them. Just recently, in 2021, the company announced the launch of its Jabra Earbuds and Iteron Move. GN Group’s profits are also equal to or greater than its competitors.Īs the company is always innovating and releasing new hearing technology, we can expect the robust nature of GN Group to continue. The company also caters to a focused market with strong, convertible assets. Overall, it seems like a fairly safe investment, as the hearing aid industry is projected to grow. If you want to buy shares of the GN Group, you can access them under GNGL on the London Stock Exchange.
Why It Mattersīesides being a huge name in the hearing aid industry, the GN Groups manufactures some of the most popular hearing aids today, include the ReSound series and Evolve headsets. The company has roots dating back at least 150 years and has acquired and teamed up with various companies, Altia, BlueParrott, and Audigy, to name a few. The GN Group is a well-known global leader in audio technology that connects people to the world through quality hearing devices. Now, in 2021, it is holding an impressively high price trend and most likely won’t see a reversal anytime soon.
But by September, it had made a near-full recovery. Shares of Sononva stock took a major hit at the start of the pandemic in March 2020. This is especially true because of Sonova’s trustworthy name in the market, selling five different brands, and its resilience. Though this may seem small, it makes the company a safe long-term investment. It is a dividend stock and currently pays out 0.69%. The global market for cochlear implants alone was 1.8 billion USD in 2020. Why It Mattersīy entering into cochlear implant technology, Sonova has set itself up to grow with the market. This acquisition combined Sonova’s existing hearing aid technology with hearing implant innovation in wireless devices and cochlear implants. Sononva started in 2007 in India and acquired Advanced Bionics in 2009. Here are the top hearing aid stocks you should consider as you make your decision. You should also consider the popularity of different kinds of hearing aids and which company is driving the type of hearing aid(s) you wish to invest in. If you plan on investing in hearing aid stock, you should diversify your portfolio and look outside of UK-based manufacturers. These are just a few reasons to look into global companies. And, not to mention, some of the highest performing companies are based outside of the UK. Experts expect the German hearing aid market to grow the fastest of all three countries. The UK may not remain #1 in hearing aids throughout the industry’s five-year market projection. Despite variations in the cost and effective use of hearing aids in the UK, the country still dominates the market, with over 1.6 million total units distributed across the private section and National Health Service. The three biggest players in the European hearing aid industry are the UK, Germany, and France. That means by 2026, the industry should reach 3.2 billion USD. One report predicts that the hearing aid market in Europe is expected to hit 2.27 billion USD this year with an annual compound growth rate of 7.6%. But the possibly unexpected reality is that the demand for hearing aids is steady, with an increasing senior population and innovations in design and capabilities driving the industry forward. When you look to invest in something, hearing aids may not be the first thing that comes to mind.